Compartmentalized bronchoalveolar IFN-γ and IL-12 response in human pulmonary tuberculosis - 22/08/11
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/lowast.gif)
Summary |
Human tuberculosis (TB) principally involves the lungs, where local immunity impacts on the load of Mycobacterium tuberculosis (M.tb). Because concomitants of local Th1 immunity are still under-explored in humans, we characterized immune responses in bronchoalveolar cells (BACs) and systemically in peripheral blood mononuclear cells (PBMCs) in persons with active pulmonary TB and in healthy community controls. PPD- and live M.tb-induced IFN-γ-production were observed in CD4+, CD8+, γδTCR+, and CD56+ alveolar T cell subpopulations and NK cells (CD3−CD56+). IFN-γ-producing CD4+ T cells (mostly CD45RO+) were more abundant (p<0.05). M.tb-induced IL-12p70, but interestingly also IL-4, was increased (p<0.05) in BACs from TB patients. Constitutive expression of IL-12Rβ1 and IL-12Rβ2 mRNA in BACs and PBMCs and IFN-γR1 in BACs was similar in both study groups. Data were normalized to account for differences in proportions of alveolar T cells and macrophages in the study groups. IFN-γ-production and its induction by IL-12R engagement occur virtually unimpaired in the bronchoalveolar spaces of patients with pulmonary TB. The reasons for the apparent failure to control M. tuberculosis growth during active pulmonary TB disease is unknown but could be the expression of locally acting immunosuppressive mechanisms that subvert the antimycobacterial effects of IFN-γ.
Le texte complet de cet article est disponible en PDF.Keywords : Human pulmonary tuberculosis, Mycobacterium tuberculosis, BAL cells, Interferon gamma, Interleukin 12, Interleukin 10, Interleukin 4, Compartmentalization
Plan
Vol 89 - N° 1
P. 38-47 - janvier 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?